Claire Knapp, the chief executive of Havas Lynx UK, is expanding her remit to take on oversight of the agency’s New York operation as part of a significant leadership overhaul. Knapp, who
More
Forecasters are warning that a powerful El Niño weather pattern is building, with significant consequences for California industrial facilities managing stormwater obligations. According to NOAA’s Climate Prediction Center, El Niño carries a
More
Crude oil inventories at Cushing, Oklahoma fell below 20 million barrels during the week ending June 19 and remained there through the week ending July 10. The drawdown represents roughly 26 percent
More
Elizabeth Oyer served as the pardoning attorney for the Department of Justice for 13 years before finding herself at the centre of a politically charged Senate confirmation hearing. Last week, Oyer testified
More
London’s FTSE 100 recovered from early session losses on Tuesday, rising 0.22% by 07:40 GMT as pressure on technology stocks began to ease. Germany’s DAX gained 0.29% and France’s CAC 40 advanced
More
Ralph Lauren (NYSE: RL) has demonstrated notable resilience in the consumer discretionary space as the latest quarterly earnings season draws comparisons across apparel and accessories stocks. The apparel and accessories segment remains
More
Bank of America (BAC) has issued a sharp warning to investors about the stock market heading into August, raising concerns about near-term volatility. The bank’s strategists have highlighted a number of risk
More
Investors are increasingly turning to artificial intelligence tools to assess portfolio risk, using platforms like ChatGPT to screen stocks for vulnerability during market downturns. The FTSE 250 index, which tracks mid-cap companies
More
New research from the Adam Smith Institute reveals that the number of real-terms millionaires in Britain has fallen to its lowest level since the 2008 financial crisis. The wealthy are not simply
More
Sarepta Therapeutics has appointed Michael Severino as its next chief executive officer, effective July 28, the rare disease drugmaker announced on Monday. Severino will succeed Doug Ingram, who announced plans to retire
More